The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.

Hans Guehring; Flavie Moreau; Benjamin Daelken; Christoph Ladel; Oliver Guenther; Asger Reinstrup Bihlet; Wolfgang Wirth; Felix Eckstein; Marc Hochberg; Philip G Conaghan

doi:10.1016/j.semarthrit.2021.03.005

The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.

Hans Guehring
, Flavie Moreau
, Benjamin Daelken
, Christoph Ladel
, Oliver Guenther
, Asger Reinstrup Bihlet
, Wolfgang Wirth (Co-author)
, Felix Eckstein (Co-author)
, Marc Hochberg
, Philip G Conaghan

Institute of Anatomy and Cell Biology Salzburg

Research output: Contribution to journal › Original Article › peer-review

44 Citations (Web of Science)

Original language	English
Pages (from-to)	450-456
Journal	SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume	51
Issue number	2
DOIs	https://doi.org/10.1016/j.semarthrit.2021.03.005
Publication status	Published - 2021

Keywords

CARTILAGE THICKNESS
METAANALYSIS
PLACEBO
RATES

Access to Document

10.1016/j.semarthrit.2021.03.005

Cite this

Guehring, H., Moreau, F., Daelken, B., Ladel, C., Guenther, O., Bihlet, A. R., Wirth, W., Eckstein, F., Hochberg, M., & Conaghan, P. G. (2021). The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial. SEMINARS IN ARTHRITIS AND RHEUMATISM, 51(2), 450-456. https://doi.org/10.1016/j.semarthrit.2021.03.005

@article{e125dded5f5c40648b0275bce0461e03,

title = "The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.",

keywords = "CARTILAGE THICKNESS, METAANALYSIS, PLACEBO, RATES",

author = "Hans Guehring and Flavie Moreau and Benjamin Daelken and Christoph Ladel and Oliver Guenther and Bihlet, \{Asger Reinstrup\} and Wolfgang Wirth and Felix Eckstein and Marc Hochberg and Conaghan, \{Philip G\}",

note = "Eckstein; Wirth: Department of Imaging and Functional Musculoskeletal Research, Institute of Anatomy \& Cell Biology, Paracelsus Medical University Salzburg \& Nuremberg, Salzburg, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University, Salzburg, Austria",

year = "2021",

doi = "10.1016/j.semarthrit.2021.03.005",

language = "English",

volume = "51",

pages = "450--456",

journal = "SEMINARS IN ARTHRITIS AND RHEUMATISM",

issn = "0049-0172",

number = "2",

}

Guehring, H, Moreau, F, Daelken, B, Ladel, C, Guenther, O, Bihlet, AR, Wirth, W , Eckstein, F, Hochberg, M & Conaghan, PG 2021, 'The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.', SEMINARS IN ARTHRITIS AND RHEUMATISM, vol. 51, no. 2, pp. 450-456. https://doi.org/10.1016/j.semarthrit.2021.03.005

TY - JOUR

T1 - The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.

AU - Guehring, Hans

AU - Moreau, Flavie

AU - Daelken, Benjamin

AU - Ladel, Christoph

AU - Guenther, Oliver

AU - Bihlet, Asger Reinstrup

AU - Wirth, Wolfgang

AU - Eckstein, Felix

AU - Hochberg, Marc

AU - Conaghan, Philip G

N1 - Eckstein; Wirth: Department of Imaging and Functional Musculoskeletal Research, Institute of Anatomy & Cell Biology, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - CARTILAGE THICKNESS

KW - METAANALYSIS

KW - PLACEBO

KW - RATES

U2 - 10.1016/j.semarthrit.2021.03.005

DO - 10.1016/j.semarthrit.2021.03.005

M3 - Original Article

C2 - 33752164

SN - 0049-0172

VL - 51

SP - 450

EP - 456

JO - SEMINARS IN ARTHRITIS AND RHEUMATISM

JF - SEMINARS IN ARTHRITIS AND RHEUMATISM

IS - 2

ER -